A Comparison Of Fecal Glucocorticoid Metabolite Concentration And Gut Microbiota Diversity In Bonobos (Pan paniscus)

Abstract

Host sex, age, diet, stress, and social environment have all been found to influence the gut microbiota. In non-human primates (NHP), recent evidence from gorillas found fecal glucocorticoid metabolite concentration (FGMC) had no significant role in structuring their gut microbiota, but there was a significant differential abundance between family Anaerolineaceae and gorilla FGMC. This pattern has yet to be examined in other NHP, like bonobos (Pan paniscus). We compared FGMC to 16S rRNA amplicons for 201 bonobo fecal samples collected in the wild across five months to evaluate the impact of stress, measured with FGMC, on the gut microbiota. Simpsons index was the only alpha diversity index to have a significant linear relationship with FGMC [R2 = 0.9643, F(4, 210) = 28.56, p = 0.0023]. FGMC level explained 1.63% of the variation in beta diversity for Jensen-Shannon Distance, 2.49% for Weighted UniFrac, and 3.53% for Unweighted UniFrac using PERMANOVAs. Differential abundance models showed seventeen taxa that were significantly correlated with FGMC. We found that genus SHD-231 in the family Anaerolinaceae was significant in our differential abundance model results, similar to western lowland gorilla abundance model results. These results suggest bonobos exhibit different patterns than gorillas in alpha and beta diversity measures and that members of the family Anaerolinaceae may be differentially affected by host stress across great apes. Incorporating FGMC into gut microbiota research can provide a more robust understanding of how stress impacts the gut microbiota of primates and humans and has important ties to overall host health.